Skip to content
value.today

GPN Vaccines, Inc.

🇺🇸 Wilmington, Delaware, USABiotechnologyFounded 2025
Total raised
$4 M
1 round on record
Latest round
$4 M
Dec 2025
First round on record
Dec 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of GPN Vaccines, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2025$4 MNo. 1$2 to $10 million

GPN Vaccines, Inc.: Raise no. 1, Dec 2025

Investors in this round

63 investors had bought by the notice of Jan 28, 2026: 63 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $10 M offered; $7 M still to sell
Smallest investment taken
$228
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Selkirk · Executive Officer
  • Timothy Hirst · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Timothy Hirst, Chief Executive Officer. Newest notice filed Jan 28, 2026. Read the notice at the SEC.

equity, optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • GPN Vaccines, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2026).

    SEC Form D · Jan 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of GPN Vaccines, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by GPN Vaccines, Inc.
NameRoleNamed in
James SelkirkExecutive officerJan 2026
Timothy HirstExecutive officerJan 2026
Timothy HirstDirectorJan 2026